badge image

Allison Connolly

Former Editor

Bristol-Myers Drops to 2-Year Low as Cancer Drug Disappoints

October 10, 2016

October 10, 2016

Bristol-Myers Drops to 2-Year Low as Cancer Drug Disappoints

October 10, 2016

October 10, 2016

Merck Tops as Lung Cancer Treatment Moves Past Chemotherapy

October 9, 2016

October 9, 2016

Bristol-Myers Lung-Cancer Drug Disappoints in Trial Analysis

March 5, 2016

March 5, 2016

Farmers Rally to Support Britain Remaining in European Union

November 19, 2015

November 19, 2015

Mallinckrodt Signals Slowing Deal Activity Amid Market Changes

October 14, 2015

October 14, 2015

Mediclinic, Al Noor Reach Accord While NMC Continues Pursuit

Mediclinic International Ltd. and Al Noor Hospitals Group Plc agreed to combine, creating a hospital company with operations the Gulf states and South Africa, after Al Noor fended off an approach by NMC Health Plc.

Mediclinic, Al Noor Reach Accord While NMC Continues Pursuit

October 9, 2015

October 9, 2015

AstraZeneca Temporarily Halts Cancer Drug Combination Trials

AstraZeneca Temporarily Halts Cancer Drug Combination Trials

June 22, 2015

June 22, 2015

Mediclinic Enters U.K. Market With $683 Million Spire Deal

March 18, 2015

March 18, 2015

Novo Sees U.S. Price Gains Even With New Sanofi Insulin

November 17, 2014

November 17, 2014

Pfizer Cancer Pact With Merck Shows Waning Astra Pursuit

July 8, 2014

July 8, 2014

AbbVie Raises Offer for Shire to $51.5 Billion in Fourth Bid

June 16, 2014

June 16, 2014

Tissue Regenix May Attract Suitors After Covidien Deal

May 1, 2014

May 1, 2014

Asbestos-Linked Cancer Attacked With New Drug Targets

April 7, 2014

April 7, 2014

Pfizer Breast Cancer Drug Helps Revive Discarded Strategy

March 21, 2014

March 21, 2014

Takeda Inflammatory Bowel Drug Wins EU Regulatory Backing

March 20, 2014

March 20, 2014

Glaxo’s Immunotherapy Fails to Help Lung Cancer Patients

March 7, 2014

March 7, 2014

Getinge Plunges on Forecast of First-Quarter Profit Drop

March 7, 2014

March 7, 2014

AstraZeneca Says Nexium Safe With Product From Ranbaxy

March 6, 2014

March 6, 2014

Merck KGaA Falls After ‘Uninspiring’ 2014 Profit Forecast

February 27, 2014

February 27, 2014

Bayer Buys China’s Dihon to Gain OTC and Herbal Therapies